Tailored Life Science Insurance

Through appointed retail and wholesale brokers, our industry specialists offer comprehensive life science insurance solutions globally.

Life Science Insurance Life Science Insurance

Insurance Solutions By Life Science Specialists

In true partnership with our agents, we offer the following life science insurance solutions, customized to the needs of your clients.

Primary

Primary

Through our LS Prime® and LS Prime® Advantage options, primary insurance coverage is offered as an admitted or non-admitted primary insurance solution.

Excess

Excess

Excess liability coverage of up to $15 million is available to protect a policyholder against unforeseeable catastrophic liability judgments.

Package

Package

Your comprehensive solution, our admitted package product provides premises operations, property, commercial auto, workers compensation, crime, and umbrella coverage.

Multinational

Multinational

Addressing localized needs of customers in more than 90 countries around the world, we offer an integrated global solution through our LS Prime® specialty including Foreign Clinical Trials, Local Products policy placements and Local Admitted Package policies.

Why Berkley Life Sciences

Learn More About Us
Learn More About Us

Helpful Links

-

Partner With Us

Partner With Us

Interested in becoming a Berkley Life Sciences appointed agency? Contact us.

Find an Agent

Find an Agent

Ready for an insurance solution that is tailored to your life science business by life science specialists? Find an agent.

Approved State Filings

Approved State Filings

Explore our approved state filings for our admitted products. Our non-admitted coverages are available in all 50 states.

All states except the following are approved: Alaska, Arkansas, California, Hawaii, Kansas, Minnesota, Montana, New Mexico, New York, North Dakota, Oklahoma, South Dakota, Vermont, Washington State, Wyoming

The Latest in Life Science

GLP-1 Medications – FDA Guidance and Compounded Products

GLP-1 Medications – FDA Guidance and Compounded Products

Not long ago, few outside the medical community had heard of semaglutide and tirzepatide—two drugs in the GLP-1 (glucagon-like peptide-1) receptor agonist class, approved for diabetes management. The medications work by decreasing caloric intake through mimicking the natural hormone GLP-1 normally released in the gut after eating. The GLP-1 agonists bind to receptors in the brain, pancreas and intestines, which helps to regulate insulin release, lower blood sugar levels, slow down digestion, and reduce appetite.

Fluoride in Drinking Water: 2025 and Beyond

Fluoride in Drinking Water: 2025 and Beyond

In 1999, the Centers for Disease Control and Prevention (CDC) recognized the fluoridation of drinking water as one of the “ten greatest public health achievements of the 20th Century.” The practice has reportedly reduced tooth decay in children by 40-70% and tooth loss in adults by 40-60%.

Biomarkers: Transforming Medicine

Biomarkers: Transforming Medicine

When Angela Haupt, a health and wellness editor at Time Magazine, had nearly two dozen vials of her blood drawn for a health startup, she received eight pages of clinical notes analyzing 105 personalized biomarkers. Did she receive valuable insights predictive of her future health, or an overload of indecipherable data? The answer is debatable. It may depend on who you ask, who is reading the information, and for what purpose. What is certain is that the use of biomarkers in the healthcare industry is expected to grow exponentially.